logo
Klarna Posts Revenue Growth as U.S. Momentum Continues

Klarna Posts Revenue Growth as U.S. Momentum Continues

STOCKHOLM—Klarna's total revenue jumped in the second quarter as momentum in the U.S., its biggest market, continued to accelerate.
The unlisted 'buy now, pay later' company posted revenue of $823 million in the period to June 30, up from $682 million in the same period a year prior, it said Thursday. Last year's figure was inflated by the sale of its online checkout solution Klarna Checkout.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sadot Group Inc (SDOT) Q2 2025 Earnings Call Highlights: Navigating Strategic Shifts Amid ...
Sadot Group Inc (SDOT) Q2 2025 Earnings Call Highlights: Navigating Strategic Shifts Amid ...

Yahoo

time25 minutes ago

  • Yahoo

Sadot Group Inc (SDOT) Q2 2025 Earnings Call Highlights: Navigating Strategic Shifts Amid ...

Revenue: $114.4 million in Q2 2025, a decrease of $58.9 million (34%) compared to Q2 2024. Gross Profit Margin: 4.4% in Q2 2025, up from 3.3% in Q2 2024, an improvement of 100 basis points. Net Income: $0.4 million in Q2 2025. EBITDA: $1.7 million in Q2 2025. Earnings Per Share (EPS): $0.07 per share, both basic and diluted. SG&A Expenses: $2.8 million in Q2 2025, an increase of $1.1 million from the previous year. Cash Balance: $0.4 million. Working Capital Surplus: $24.2 million. Accounts Receivable: $44.1 million. Strategic Investment: $13.4 million assigned to acquire a 37.5% equity stake in a carbon project in Indonesia. Warning! GuruFocus has detected 4 Warning Signs with SDOT. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Sadot Group Inc (NASDAQ:SDOT) posted its fifth consecutive quarter of positive net income and EBITDA, demonstrating consistent financial improvement. The company has successfully transitioned from a restaurant-only concept to an emerging player in the global food supply chain. Gross profit improved by 100 basis points to 4.4% in Q2 2025, attributed to focusing on higher-margin trades and specialty items. Sadot Group Inc (NASDAQ:SDOT) is leveraging AI and data-driven technologies to enhance decision-making and operational efficiency. The company is strategically expanding its global footprint and exploring vertical integration opportunities to strengthen control over the supply chain. Negative Points Revenue for Sadot Agri-Foods decreased by 34% compared to Q2 2024, primarily due to selective trading with more favorable margins. The sale of the restaurant segment has been slow, causing resource allocation issues and shareholder confusion. SG&A expenses increased by $1.1 million compared to the previous year, reflecting reclassification of expenses and increased administrative costs. The company had to raise $2.5 million due to delays in receivables collection and the restaurant sale, indicating cash flow challenges. There have been significant changes in the Board and management, which may indicate instability during the company's strategic pivot. Q & A Highlights Q: What is the status on the sale of the restaurants? A: Chagay Ravid, CEO, expressed dissatisfaction with the slow progress in selling the restaurants. Despite multiple LOIs and ongoing due diligence with potential buyers, the sale is crucial to reduce costs, generate cash, and focus on the agricultural business. The company is in final negotiations with strong candidates interested in acquiring both Muscle Maker Grill and Pokemoto. Q: Why did the company recently raise $2.5 million, and what are the proceeds being used for? A: The capital was raised due to delays in collecting receivables and closing the restaurant sale. It was a straight equity deal without any warrants. Q: How do tariffs affect Sadot, if at all? A: Paul Sansom, CFO, stated that tariffs have minimal impact on Sadot as most trades occur outside the United States. The company can move transactions globally to avoid US tariffs if necessary. Q: Why have there been so many changes in the Board and management recently? A: Chagay Ravid explained that the strategic shift from a US-based restaurant company to an international player in the global food supply chain necessitates personnel with specific skill sets in finance and technology. These changes are part of the company's growth and strategic pivot. Q: What are the company's strategic pillars for future growth? A: The CEO outlined five strategic pillars: geographic and vertical expansion, margin optimization and cost efficiency, technology and digital infrastructure, strengthening management and culture, and sustainable and ethical growth. These pillars aim to transform Sadot into a diversified, technology-enabled global agri-business. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio

FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads
FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads

Yahoo

time29 minutes ago

  • Yahoo

FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads

Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced that it is monitoring a safety issue with Boston Scientific Corporation's ENDOTAK RELIANCE defibrillation leads, which are used with implantable cardioverter-defibrillators to prevent sudden cardiac death. Earlier this year, the company sent a letter to healthcare providers on July 24, warning that calcification of the leads' expanded polytetrafluoroethylene/ePTFE coating could lead to a gradual increase in low-voltage shock impedance/LVSI. This can reduce the effectiveness of life-saving shocks and even result in patient death. A surgeon examining a patient's brain in an operating room, paramedics nearby. The affected leads were manufactured and distributed between 2002 and 2021 and are no longer available. As of July 24, Boston Scientific had reported 386 serious injuries and 16 deaths linked to this issue. The FDA has categorized this as a potentially high-risk problem and is actively reviewing data to determine further regulatory action. Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It has 2 segments: MedSurg and Cardiovascular. While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Salesforce, NICE Expand Partnership for AI-Powered Customer Service
Salesforce, NICE Expand Partnership for AI-Powered Customer Service

Yahoo

time29 minutes ago

  • Yahoo

Salesforce, NICE Expand Partnership for AI-Powered Customer Service

Salesforce Inc. (NYSE:CRM) is one of the best high-volume stocks to invest in. On August 12, NICE Ltd. (NASDAQ:NICE) announced an expanded partnership with Salesforce to improve customer service experiences through a deeper integration of their respective platforms. The collaboration focuses on bringing NICE's AI-powered CX and intelligent orchestration capabilities together with Agentforce in Salesforce Service Cloud. The partnership builds on the companies' previous collaboration, which started in 2022 with the launch of 'Bring Your Own Telephony' with Salesforce Service Cloud Voice. The new agreement will further invest in enabling 'Bring Your Own Contact Center' and integrate NICE's Workforce Engagement Management/WEM capabilities into the Service Cloud's unified desktop. A customer service team in an office setting using the company's Customer 360 platform to communicate with customers. As part of this collaboration, NICE plans to join the Salesforce Zero Copy Partner Network. This will make it the first company in the Contact Center ecosystem to enable a bidirectional Zero Copy integration with Salesforce Data Cloud. This integration will create a shared data foundation between NICE CXone Mpower and Salesforce Data Cloud, eliminating data silos and allowing for real-time, AI-driven orchestration using complete customer journey context. Salesforce Inc. (NYSE:CRM) provides customer relationship management/CRM technology that connects companies and customers worldwide. NICE Ltd. (NASDAQ:NICE) provides cloud platforms for AI-driven digital business solutions worldwide. While we acknowledge the potential of CRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store